It depends on several factors including your overall health condition and blood glucose levels at the time of donation
The STEP trials also showed that weight loss continued throughout most of the treatment period, with most participants still losing weight at 68 weeks
In comparison, the number of young people receiving other medications stayed relatively flat over the same period
Cardiologists will need to counsel patients through that and acclimate them to giving these drugs by subcutaneous injection. Meanwhile, he adds, future research is needed to address whether semaglutide exerts the same protective effects for primary prevention of cardiovascular disease in high-risk individuals with overweight or obesity
If you are concerned about your weight or metabolic health, the most appropriate first step is to speak with your GP
Gastrointestinal effects usually settle across the first month, then return temporarily after each increase